Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Accumulated Depreciation, Depletion, and Amortization
QFR218385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
126,862.00
Year-over-Year Change
9.79%
Date Range
10/1/2000 - 1/1/2025
Summary
This trend tracks accumulated depreciation, depletion, and amortization for U.S. pharmaceutical and medicines corporations, providing insight into capital investment and asset value reduction. It serves as a critical indicator of industry capital expenditure and long-term asset management strategies.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
Accumulated depreciation represents the total reduction in value of a corporation's tangible and intangible assets over time, reflecting ongoing capital investment and asset lifecycle management. Economists use this metric to assess industry capital intensity, investment patterns, and potential technological reinvestment.
Methodology
Data is collected through quarterly financial reports submitted by pharmaceutical corporations, aggregated and standardized by federal economic reporting agencies.
Historical Context
This trend helps policymakers and investors understand capital investment trends, technological reinvestment, and long-term financial health in the pharmaceutical sector.
Key Facts
- Tracks cumulative asset value reduction in pharmaceutical corporations
- Provides insights into long-term capital investment strategies
- Reflects technological reinvestment and asset lifecycle management
FAQs
Q: What does accumulated depreciation indicate?
A: Accumulated depreciation shows the total reduction in value of a corporation's assets over time, reflecting ongoing capital investment and asset wear.
Q: Why is this trend important for investors?
A: It helps investors understand a company's capital investment strategies, asset management, and potential for technological reinvestment.
Q: How is this data collected?
A: Data is gathered through quarterly financial reports submitted by pharmaceutical corporations and standardized by federal economic reporting agencies.
Q: What can this trend reveal about the pharmaceutical industry?
A: It provides insights into capital intensity, technological investment, and long-term financial health of pharmaceutical corporations.
Q: How frequently is this data updated?
A: The data is typically updated quarterly, providing a consistent view of corporate asset management over time.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Miscellaneous Manufacturing: Total Liabilities
QFRTL339USNO
Quarterly Financial Report: U.S. Corporations: All Other Electronic Products: Other Direct Credits (Charges) to Retained Earnings (Net)
QFRD122334USNO
Quarterly Financial Report: U.S. Corporations: Wood Products: Cash Dividends Charged to Retained Earnings This Quarter
QFR120321USNO
Quarterly Financial Report: U.S. Corporations: Nonmetallic Mineral Products: Retained Earnings at Beginning of Quarter
QFRD119327USNO
Quarterly Financial Report: U.S. Corporations: All Other Chemicals: Cash Dividends Charged to Retained Earnings This Quarter
QFR120325USNO
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Land and Mineral Rights
QFR217OTRUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Accumulated Depreciation, Depletion, and Amortization [QFR218385USNO], retrieved from FRED.
Last Checked: 8/1/2025